Company news
Cambridge Cognition Holdings PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Result of AGM and Board Changes
May 27, 2021
New £0.5m contract for cognitive at home testing
April 8, 2021
Cambridge Cognition provides cognitive assessments in an at-home clinical trial
April 7, 2021
£1.3 million contract for a schizophrenia trial
March 30, 2021
Results for the year ended 31 December 2020
March 23, 2021
Investor Presentation
March 11, 2021
Trading Update, Board Change & Notice of Results
January 19, 2021
New digital health contract worth over £700,000
December 21, 2020
New £750,000 digital health contract
October 7, 2020
Appointment of Non-Executive Director
September 14, 2020
£2m contract for three schizophrenia trials
September 1, 2020
New virtual study with COVID-19 healthcare workers
July 15, 2020
Annual Report & Notice of AGM
June 30, 2020
Grant of Options
June 9, 2020
Capital Markets Showcase
June 5, 2020
Over £1 million of New Contract Wins
May 27, 2020
Preliminary Results - Year ended 31 December 2019
May 5, 2020
Delayed Preliminary Results
March 23, 2020
Award of Innovative Medicines Initiative grant
March 19, 2020
£1.37 million of new eCOA contracts
March 17, 2020
Result of General Meeting
March 9, 2020
Fundraising to raise £1.4m & Notice of GM
February 19, 2020
Cambridge Cognition expands eCOA and wins contract
November 25, 2019
Alzheimer's drug potential for Cambridge Cognition
October 25, 2019
Director/PDMR Shareholding
September 26, 2019
Dr. Nick Kerton
August 14, 2019
Expansion in Chinese market
August 12, 2019
New Commercial Partnership for NeuroVocalix
July 19, 2019
Board Changes
April 25, 2019
£1.3m digital health contract win
March 19, 2019
Appointment of Chief Operating Officer
March 7, 2019
First Partnership in India and New Product Launch
January 31, 2019
Trading update and notice of results
December 19, 2018
Contract win in growing eCOA revenue stream
November 14, 2018
Half Yearly Report
September 20, 2018
Company signs first NeuroVocalix contract
September 19, 2018
NeuroVocalixT platform ready for clinical trials
September 13, 2018
CANTAB incorporated in population health platform
August 1, 2018
New product to improve workplace mental health
June 20, 2018
Partnership to tackle growing mental health need
June 7, 2018
New client signs with Cognition Kit software
May 31, 2018
Recruitment contracts show strong growth
April 10, 2018
Major Contract Win and Funding Award
March 26, 2018
Final Results
March 22, 2018
Wearable technology demonstrates high compliance
November 28, 2017
Issue of Equity
October 6, 2017
Half-year Report
September 21, 2017
Award of Funding
September 12, 2017
Speech recognition for clinical trials
June 7, 2017
Result of AGM & Board Change
May 25, 2017
Calls
- Cambridge Cognition Holdings (LSE:COG) — Interim Results for the six months to 30 June 2026
Sep 16, 2026
Transcript - Cambridge Cognition Holdings (LSE:COG) — Results for the year ended 31 December 2025 Q&A Session
Apr 13, 2026
Transcript - Cambridge Cognition Holdings (LSE:COG) — 2025 Interim Results
Sep 3, 2025
Transcript - Cambridge Cognition Holdings (LSE:COG) — Preliminary Results
May 1, 2025
Transcript
Decks
- H1 2025 Earnings Presentation
Earnings · 13 slides · Sep 3, 2025
- FY2024 Earnings Presentation
Earnings · 15 slides · 2025